Episurf Medical AB (publ) (ST:EPIS-B) — Market Cap & Net Worth
Market Cap & Net Worth: Episurf Medical AB (publ) (EPIS-B)
Episurf Medical AB (publ) (ST:EPIS-B) has a market capitalization of $10.36 Million (Skr96.24 Million) as of August 4, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #26943 globally and #585 in its home market, demonstrating a 1.75% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Episurf Medical AB (publ)'s stock price Skr0.06 by its total outstanding shares 1659288021 (1.66 Billion). See EPIS-B capex to operating cash flow ratio to understand how much of operating cash flow is reinvested back into capital assets.
Episurf Medical AB (publ) Market Cap History: 2015 to 2026
Episurf Medical AB (publ)'s market capitalization history from 2015 to 2026. Data shows change from $3.12 Billion to $10.36 Million (-42.38% CAGR).
Episurf Medical AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Episurf Medical AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.49x
Episurf Medical AB (publ)'s market cap is 0.49 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.67 Billion | $2.41 Million | -$61.67 Million | 1109.72x | N/A |
| 2017 | $964.26 Million | $2.49 Million | -$61.09 Million | 387.21x | N/A |
| 2018 | $517.84 Million | $4.00 Million | -$57.80 Million | 129.46x | N/A |
| 2019 | $208.92 Million | $4.90 Million | -$70.60 Million | 42.64x | N/A |
| 2020 | $541.05 Million | $5.00 Million | -$64.60 Million | 108.21x | N/A |
| 2021 | $812.47 Million | $6.50 Million | -$69.50 Million | 125.00x | N/A |
| 2022 | $419.63 Million | $6.60 Million | -$77.30 Million | 63.58x | N/A |
| 2023 | $176.78 Million | $10.30 Million | -$94.80 Million | 17.16x | N/A |
| 2024 | $24.43 Million | $13.00 Million | -$76.00 Million | 1.88x | N/A |
| 2025 | $6.62 Million | $13.50 Million | -$58.20 Million | 0.49x | N/A |
Competitor Companies of EPIS-B by Market Capitalization
Companies near Episurf Medical AB (publ) in the global market cap rankings as of August 4, 2026.
Key companies related to Episurf Medical AB (publ) by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #113 globally with a market cap of $186.27 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #180 globally with a market cap of $130.57 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #239 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #113 | Abbott Laboratories | NYSE:ABT | $186.27 Billion | $107.12 |
| #180 | Stryker Corporation | NYSE:SYK | $130.57 Billion | $341.20 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #239 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $86.68 |
Episurf Medical AB (publ) Historical Marketcap From 2015 to 2026
Between 2015 and today, Episurf Medical AB (publ)'s market cap moved from $3.12 Billion to $ 10.36 Million, with a yearly change of -42.38%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr10.36 Million | +56.33% |
| 2025 | Skr6.62 Million | -72.88% |
| 2024 | Skr24.43 Million | -86.18% |
| 2023 | Skr176.78 Million | -57.87% |
| 2022 | Skr419.63 Million | -48.35% |
| 2021 | Skr812.47 Million | +50.17% |
| 2020 | Skr541.05 Million | +158.97% |
| 2019 | Skr208.92 Million | -59.66% |
| 2018 | Skr517.84 Million | -46.30% |
| 2017 | Skr964.26 Million | -63.88% |
| 2016 | Skr2.67 Billion | -14.57% |
| 2015 | Skr3.12 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of Episurf Medical AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.36 Million USD |
| MoneyControl | $10.36 Million USD |
| MarketWatch | $10.36 Million USD |
| marketcap.company | $10.36 Million USD |
| Reuters | $10.36 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Episurf Medical AB (publ)
Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It offers Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient's knee joint; Episealer implant, which is designed to fit anatomy and size of the lesio… Read more